Clinical trials
Phase 1/2 Osteoarthritis, Knee trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
78 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 7 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Unknown status | 21 |
| Withdrawn | 7 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
| Not yet recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Steadman Philippon Research Institute | 3 |
| Marigot Ltd. | 2 |
| Medical University of Warsaw | 2 |
| Red de Terapia Celular | 2 |
| Translational Biosciences | 2 |
| Yooyoung Pharmaceutical Co., Ltd. | 2 |
| Aarhus University Hospital | 1 |
| Aditya K Aggarwal | 1 |
| Ampio Pharmaceuticals. Inc. | 1 |
| Arizona State University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoarthritis, Knee | 78 |
| Osteoarthritis | 38 |
| Pain | 5 |
| Joint Diseases | 4 |
| Osteoarthritis, Hip | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Inflammation | 2 |
| Knee Injuries | 2 |
| Musculoskeletal Diseases | 2 |
| Obesity | 2 |
Trials
Showing 51 to 75 of 78. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.